PROCEPT BioRobotics Corporation
MX ˙ BMV ˙ US74276L1052
SecurityMX:PRCT / PROCEPT BioRobotics Corporation
InstitutionPnc Financial Services Group, Inc.
Latest Disclosed Ownership124 shares
Latest Disclosed Value $ 3,101
Pnc Financial Services Group, Inc. reports 97.38% decrease in ownership of PRCT / PROCEPT BioRobotics Corporation

On May 8, 2026 - Pnc Financial Services Group, Inc. filed a 13F-HR form disclosing ownership of 124 shares of PROCEPT BioRobotics Corporation (MX:PRCT) valued at $3,101 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 4,739 shares of PROCEPT BioRobotics Corporation. This represents a change in shares of -97.38% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F PROCEPT BIOROBOTICS COM 74276L105 124 -4,615 -97.38 3 -97.99 0.0000
2026-02-06 2025-12-31 13F PROCEPT BIOROBOTICS COM 74276L105 4,739 -4,389 -48.08 149 -54.15 0.0001
2025-11-07 2025-09-30 13F PROCEPT BIOROBOTICS COM 74276L105 9,128 4,408 93.39 326 19.93 0.0002
2025-08-08 2025-06-30 13F PROCEPT BIOROBOTICS COM 74276L105 4,720 4,150 728.07 272 721.21 0.0002
2025-05-09 2025-03-31 13F PROCEPT BIOROBOTICS COM 74276L105 570 -1,455 -71.85 33 -79.75 0.0000
2025-02-07 2024-12-31 13F PROCEPT BIOROBOTICS COM 74276L105 2,025 -1,582 -43.86 163 -43.40 0.0001
2024-11-08 2024-09-30 13F PROCEPT BIOROBOTICS COM 74276L105 3,607 2,408 200.83 289 294.52 0.0002
2024-08-09 2024-06-30 13F PROCEPT BIOROBOTICS COM 74276L105 1,199 1,175 4,895.83 73 7,200.00 0.0000
2024-05-10 2024-03-31 13F PROCEPT BIOROBOTICS COM 74276L105 24 24 1 0.0000
2024-03-22 2023-12-31 13F/A-1 PROCEPT BIOROBOTICS COM 74276L105 0 -34 -100.00 0 -100.00
2024-02-09 2023-12-31 13F PROCEPT BIOROBOTICS COM 74276L105 0 -34 0
2023-11-13 2023-09-30 13F PROCEPT BIOROBOTICS COM 74276L105 34 34 1 0.0000
2022-11-10 2022-09-30 13F PROCEPT BIOROBOTICS COM 74276L105 0 -26,398 -100.00 0 -100.00
2022-08-12 2022-06-30 13F PROCEPT BIOROBOTICS COM 74276L105 26,398 26,398 863 0.0008
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.